News
FDA approves pembrolizumab for sorafenib-intolerant HCC patients
Approval was based on an objective response rate of 17% in KEYNOTE-224, a single-arm trial of 104 patients with hepatocellular carcinoma who were...
News
FDA approves Yupelri for COPD maintenance therapy
Revefenacin is a long-acting muscarinic antagonist.
News
FDA authorizes emergency use of rapid fingerstick test for Ebola
The DPP Ebola Antigen System can provide rapid results in locations where health care providers lack access to authorized Ebola virus nucleic acid...
News
ICYMI: Elotuzumab reduces progression risk in lenalidomide-refractory multiple myeloma
Patients had a significantly lower risk of progression or death when receiving elotuzumab plus pomalidomide and dexamethasone, compared with...
News
FDA approves adalimumab biosimilar Hyrimoz
Hyrimoz is the third adalimumab biosimilar approved by the FDA.
News
FDA approves sufentanil for adults with acute pain
The opioid is to used for only adult patients in settings that are closely controlled.
News
Yoga feasible, provides modest benefits for women with urinary incontinence
Overall incontinence frequency was reduced by 76% in the yoga group and by 56% in the control group.
News
Over one-third of psoriasis patients have PsA
And more top psoriasis posters from the Las Vegas Dermatology Seminar
News
FDA approves adalimumab biosimilar Hyrimoz
Hyrimoz is the third adalimumab biosimilar approved by the FDA.